BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31555865)

  • 1. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
    Yano K; Kaji T; Onishi S; Machigashira S; Nagai T; Harumatsu T; Yamada K; Yamada W; Muto M; Nakame K; Mukai M; Ieiri S
    Pediatr Surg Int; 2019 Dec; 35(12):1345-1351. PubMed ID: 31555865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
    Yano K; Sugita K; Muto M; Matsukubo M; Onishi S; Kedoin C; Matsui M; Murakami M; Harumatsu T; Yamada K; Yamada W; Kumagai K; Ido A; Kaji T; Ieiri S
    J Pediatr Surg; 2022 Jul; 57(7):1286-1292. PubMed ID: 35396090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome.
    Onishi S; Kaji T; Yamada W; Nakame K; Moriguchi T; Sugita K; Yamada K; Kawano T; Mukai M; Souda M; Yamada S; Yoshioka T; Tanimoto A; Ieiri S
    Pediatr Surg Int; 2016 Dec; 32(12):1165-1171. PubMed ID: 27651372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.
    Liu X; Nelson DW; Holst JJ; Ney DM
    Am J Clin Nutr; 2006 Nov; 84(5):1142-50. PubMed ID: 17093168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
    Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G610-22. PubMed ID: 22744334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.
    Koopmann MC; Chen X; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1222-30. PubMed ID: 20864657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats.
    Onishi S; Kaji T; Yamada W; Nakame K; Machigashira S; Kawano M; Yano K; Harumatsu T; Yamada K; Masuya R; Kawano T; Mukai M; Hamada T; Souda M; Yoshioka T; Tanimoto A; Ieiri S
    Peptides; 2018 Aug; 106():59-67. PubMed ID: 29966680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
    Martin GR; Wallace LE; Sigalet DL
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
    Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
    J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-Like Peptide 2 Stimulates Postresection Intestinal Adaptation in Preterm Pigs by Affecting Proteins Related to Protein, Carbohydrate, and Sulphur Metabolism.
    Jiang P; Vegge A; Thymann T; Wan JM; Sangild PT
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(8):1293-1300. PubMed ID: 27503937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome.
    Machigashira S; Kaji T; Onishi S; Yamada W; Yano K; Yamada K; Masuya R; Kawano T; Nakame K; Mukai M; Ieiri S
    Pediatr Surg Int; 2018 Feb; 34(2):203-209. PubMed ID: 29039050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential action of TGR5 agonists on GLP-2 secretion and promotion of intestinal adaptation in a piglet short bowel model.
    Lin S; Stoll B; Robinson J; Pastor JJ; Marini JC; Ipharraguerre IR; Hartmann B; Holst JJ; Cruz S; Lau P; Olutoye O; Fang Z; Burrin DG
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G641-G652. PubMed ID: 30920308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
    Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
    PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum.
    Slim GM; Lansing M; Wizzard P; Nation PN; Wheeler SE; Brubaker PL; Jeppesen PB; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):891-898. PubMed ID: 30614011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased liver damage in rat models of short bowel syndrome through DPP4 inhibition.
    Sueyoshi R; Furuhashi N; Ishii J; Yamaguchi R; Kawakami M; Tanabe K; Segawa O
    Pediatr Surg Int; 2022 Nov; 39(1):21. PubMed ID: 36449115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanisms underlying the effect of hepatocyte growth factor on liver injury in short bowel syndrome model rats.
    Sugita K; Yano K; Matsukubo M; Iwamoto Y; Ogata M; Takada L; Kedoin C; Murakami M; Harumatsu T; Onishi S; Kawano T; Muto M; Kumagai K; Ido A; Kaji T; Ieiri S
    Pediatr Surg Int; 2023 Nov; 40(1):8. PubMed ID: 37999791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of Intestinal Adaptation by Hepatocyte Growth Factor in the Jejunum: An Experimental Study in a Short-Bowel Rat Model.
    Sugita K; Yano K; Onishi S; Iwamoto Y; Ogata M; Takada L; Kedoin C; Masakazu M; Harumatsu T; Kawano T; Muto M; Kumagai K; Ido A; Kaji T; Ieiri S
    J Pediatr Surg; 2024 Apr; 59(4):627-633. PubMed ID: 38160183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.